Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May:118:35-39.
doi: 10.1016/j.pediatrneurol.2021.01.011. Epub 2021 Feb 5.

Brain-Derived Neurotrophic Factor in Neonatal Seizures

Affiliations
Review

Brain-Derived Neurotrophic Factor in Neonatal Seizures

Brennan J Sullivan et al. Pediatr Neurol. 2021 May.

Abstract

Brain-derived neurotrophic factor (BDNF), a member of the neurotrophin family, has an extensively studied classical role in neuronal growth, differentiation, survival, and plasticity. Neurotrophic, from the Greek neuro and trophos, roughly translates as "vital nutrition for the brain." During development, BDNF and its associated receptor tyrosine receptor kinase B are tightly regulated as they influence the formation and maturation of neuronal synapses. Preclinical research investigating the role of BDNF in neurological disorders has focused on the effects of decreased BDNF expression on the development and maintenance of neuronal synapses. In contrast, heightened BDNF-tyrosine receptor kinase B activity has received less scrutiny for its role in neurological disorders. Recent studies suggest that excessive BDNF-tyrosine receptor kinase B signaling in the developing brain may promote the hyperexcitability that underlies refractory neonatal seizures. This review will critically examine BDNF-tyrosine receptor kinase B signaling in the immature brain, its role in the emergence of refractory neonatal seizures, and the potential of targeting BDNF-TrkB signaling as a novel antiseizure strategy.

Keywords: BDNF; Development; Epilepsy; KCC2; Seizures; TrkB.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest statement

SDK is listed as an author on US patent 10525024B2, “Methods for rescuing phenobarbital-resistance of seizures by ANA-12 or ANA-12 in combination with CLP290.”

Figures

Figure 1.
Figure 1.
Post-ischemic BDNF-TrkB signaling is proposed to facilitate the emergence of phenobarbital unresponsive neonatal seizures. (A) Schematized inhibitory synapses in a non-pathological neonatal brain, (B) post-ischemic insult, and (C) ANA12 treated post-ischemic insult. (D) Legend for proteins, molecules, and cell types of interest. An improved understanding of the multiples levels of BDNF regulation in neonatal seizures is necessary.

Similar articles

Cited by

References

    1. Maynard KR, Hill JL, Calcaterra NE, Palko ME, Kardian A, Paredes D, et al. Functional Role of BDNF Production from Unique Promoters in Aggression and Serotonin Signaling. Neuropsychopharmacology 2016;41:1943–55. 10.1038/npp.2015.349. - DOI - PMC - PubMed
    1. McNamara JO, Scharfman HE. Temporal Lobe Epilepsy and the BDNF Receptor, TrkB. In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV, editors. Jasper’s Basic Mechanisms of the Epilepsies. 4th ed., Bethesda (MD): National Center for Biotechnology Information (US); 2012. - PubMed
    1. Gottmann K, Mittmann T, Lessmann V. BDNF signaling in the formation, maturation and plasticity of glutamatergic and GABAergic synapses. Exp Brain Res 2009;199:203–34. 10.1007/s00221-009-1994-z. - DOI - PubMed
    1. Rivera C, Voipio J, Thomas-Crusells J, Li H, Emri Z, Sipilä S, et al. Mechanism of Activity-Dependent Downregulation of the Neuron-Specific K-Cl Cotransporter KCC2. J Neurosci 2004;24:4683–91. 10.1523/JNEUROSCI.5265-03.2004. - DOI - PMC - PubMed
    1. Riffault B, Kourdougli N, Dumon C, Ferrand N, Buhler E, Schaller F, et al. Pro-Brain-Derived Neurotrophic Factor (proBDNF)-Mediated p75NTR Activation Promotes Depolarizing Actions of GABA and Increases Susceptibility to Epileptic Seizures. Cereb Cortex 2018;28:510–27. 10.1093/cercor/bhw385. - DOI - PubMed

Publication types

Substances